Physician profile
Andrew B Limbert
NPI 1043265606
$4,929.70
in general payments reported to CMS, 2019-2025
7 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $1,000 · 2021: $116 · 2022: $280 · 2023: $1,879 · 2024: $110 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,280 · Food and Beverage: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,279.66 |
| Food and Beverage | $1,141.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,902.33 | 2019-2025 | Persona, Avitus Bone Harvester, Tapestry |
| Pinnacle, INC | $764.72 | 2020 | |
| Smith+Nephew, INC. | $448.13 | 2019-2024 | Evos, Trigen Intertan |
| Stryker Corporation | $279.35 | 2022-2025 | Pangea |
| Heron Therapeutics, INC. | $239.29 | 2023 | Zynrelef |
| Depuy Synthes Sales INC. | $218.10 | 2020-2025 | Inhance |
| Sanara Medtech INC. | $77.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Limbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.